Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
1.130
+0.070 (6.60%)
At close: Oct 9, 2025, 4:00 PM EDT
1.140
+0.010 (0.88%)
After-hours: Oct 9, 2025, 7:58 PM EDT
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $4.20 million as of October 9, 2025. Its market cap has increased by 77.32% in one year.
Market Cap
4.20M
Enterprise Value
99.79M
1-Year Change
77.32%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $8.96M to $4.20M, a decrease of -53.19%. That is a compound annual growth rate of -2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 3.94M | 28.31% |
| Dec 31, 2024 | 3.07M | -6.42% |
| Dec 29, 2023 | 3.28M | -56.55% |
| Dec 30, 2022 | 7.55M | 26.22% |
| Dec 31, 2021 | 5.98M | -62.47% |
| Dec 31, 2020 | 15.93M | 268.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |